Protocols

Gonadorelin (GnRH agonist) dosing and administration protocols vary significantly based on the clinical indication and patient population. The following protocols are reported in the medical literature:

Central Precocious Puberty

Based on systematic reviews and clinical studies, GnRH agonist therapy for central precocious puberty typically involves long-acting formulations administered monthly or every few months. Treatment continues until an appropriate age for puberty onset is reached. Specific dosing varies by preparation and individual patient factors.

Assisted Reproductive Technology

In IVF/ICSI cycles, gonadorelin protocols include:

Luteal phase support: Daily administration compared to progesterone/estradiol combinations
Ovarian stimulation protocols: Used in combination with or as alternatives to GnRH antagonists
Ultralong protocols: Extended pretreatment courses, particularly in patients with adenomyosis

Prostate Cancer

For androgen deprivation therapy, GnRH agonists are administered as part of comprehensive treatment regimens, often in combination with radiation therapy approaches including stereotactic body radiotherapy (SBRT) and high-dose-rate brachytherapy.

Endometriosis and Adenomyosis

Treatment protocols involve extended courses to suppress ovarian function, with duration and dosing tailored to symptom management and patient tolerance.

Growth-Related Applications

Some protocols combine GnRH analog therapy with supplemental treatments like gamma-aminobutyric acid for children with growth retardation, though this represents emerging research.

Important Disclaimer: This information describes general protocols reported in medical literature and is not personalized medical advice. Gonadorelin dosing, administration route, frequency, and duration must be individualized based on specific clinical indication, patient characteristics, and response to treatment. Always consult with qualified healthcare providers for appropriate dosing recommendations and monitoring protocols specific to individual cases.

Gonadorelin

Member access required